Celonic Group Announces CEO Transition
Celonic Group Announces CEO Transition Basel, Switzerland Dr. Samanta Cimitan to Depart at End of 2026 to Assume a Senior […]
The University Hospital Cologne (UHC), in collaboration with the German Center for Infection Research (DZIF) has selected the Celonic Group for process development and GMP manufacturing of a monoclonal antibody
The University Hospital Cologne (UHC), in collaboration with the German Center for Infection Research (DZIF) has selected the Celonic Group
Celonic AG and Leukocare AG Announce Development Collaboration to Support Joint Clients with Complex Biologics and Advanced Drug Product Profiles
Celonic AG and Leukocare AG Announce Development Collaboration to Support Joint Clients with Complex Biologics and Advanced Drug Product Profiles
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform Celonic Group
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing. Celonic Group leverages Merck’s Breez™ micro-bioreactor technology to optimize
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab LINDIS Biotech has